These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6374620)

  • 1. Oligonucleotide mutagenesis of the lacPUV5 promoter.
    Munson LM; Mandecki W; Caruthers MH; Reznikoff WS
    Nucleic Acids Res; 1984 May; 12(9):4011-7. PubMed ID: 6374620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion analysis of RNA polymerase interaction sites in the Escherichia coli lactose operon regulatory region.
    Yu XM; Reznikoff WS
    J Mol Biol; 1986 Apr; 188(4):545-53. PubMed ID: 2426457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutagenesis directed by phosphotriester analogs of oligonucleotides: a way to site-specific mutagenesis in vivo].
    Petrenko VA; Kipriianov SM; Boldyrev AN; Pozdniakov PI
    Mol Gen Mikrobiol Virusol; 1989 Mar; (3):35-9. PubMed ID: 2657415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variants of phage M13 DNA containing a fragment of the beta-galactosidase gene--a convenient mutation system for the study of oligonucleotide-directed mutagenesis].
    Petrenko VA; Semenova LN; Kipriianov SM; Boldyrev AN; Sivolobova GF
    Bioorg Khim; 1986 Dec; 12(12):1612-24. PubMed ID: 3028430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybridization with synthetic oligonucleotides.
    Szostak JW; Stiles JI; Tye BK; Chiu P; Sherman F; Wu R
    Methods Enzymol; 1979; 68():419-28. PubMed ID: 161605
    [No Abstract]   [Full Text] [Related]  

  • 6. Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.
    Zoller MJ; Smith M
    Nucleic Acids Res; 1982 Oct; 10(20):6487-500. PubMed ID: 6757864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gapped duplex DNA approach to oligonucleotide-directed mutation construction.
    Kramer W; Drutsa V; Jansen HW; Kramer B; Pflugfelder M; Fritz HJ
    Nucleic Acids Res; 1984 Dec; 12(24):9441-56. PubMed ID: 6096830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional slippage during the transcription initiation process at a mutant lac promoter in vivo.
    Xiong XF; Reznikoff WS
    J Mol Biol; 1993 Jun; 231(3):569-80. PubMed ID: 7685823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved positive selection plasmid vector constructed by oligonucleotide mediated mutagenesis.
    Nilsson B; Uhlén M; Josephson S; Gatenbeck S; Philipson L
    Nucleic Acids Res; 1983 Nov; 11(22):8019-30. PubMed ID: 6316281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Site-localized mutagenesis directed by phosphotriester analogs of oligonucleotides].
    Petrenko VA; Pozdniakov PI; Kipriianov SM; Boldyrev AN; Semenova LN
    Bioorg Khim; 1986 Aug; 12(8):1088-100. PubMed ID: 3778534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient synthetic primer for the M13 cloning dideoxy sequencing system.
    Lau PC; Spencer JH
    Biosci Rep; 1982 Sep; 2(9):687-96. PubMed ID: 6753962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved oligonucleotide site-directed mutagenesis using M13 vectors.
    Carter P; Bedouelle H; Winter G
    Nucleic Acids Res; 1985 Jun; 13(12):4431-43. PubMed ID: 2989795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved oligonucleotide-directed mutagenesis using M13 vectors.
    Carter P
    Methods Enzymol; 1987; 154():382-403. PubMed ID: 2828857
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutations reducing the activity of c17, a promoter of phage lambda formed by a tandem duplication.
    Mozola MA; Friedman DI; Crawford CL; Wulff DL; Shimatake H; Rosenberg M
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1122-5. PubMed ID: 375226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An E. coli DNA fragment 118 base pairs in length provides dnaY+ complementing activity.
    Mullin DA; Garcia GM; Walker JR
    Cell; 1984 Jun; 37(2):669-74. PubMed ID: 6373018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The construction of a synthetic Escherichia coli trp promoter and its use in the expression of a synthetic interferon gene.
    Windass JD; Newton CR; De Maeyer-Guignard J; Moore VE; Markham AF; Edge MD
    Nucleic Acids Res; 1982 Nov; 10(21):6639-57. PubMed ID: 6184675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convenient modification of the method for oligonucleotide-directed in vitro mutagenesis of cloned DNA.
    Efimov VA; Mirskikh OV; Chakhmakhcheva OG; Ovchinnikov YuA
    FEBS Lett; 1985 Feb; 181(2):407-11. PubMed ID: 3882458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the lac regulatory region: second-site changes that activate mutant promoters.
    Rothmel RK; LeClerc JE
    Nucleic Acids Res; 1989 May; 17(10):3909-25. PubMed ID: 2660105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro site-directed mutagenesis with synthetic DNA oligonucleotides yields unexpected deletions and insertions at high frequency.
    Osinga KA; Van der Bliek AM; Van der Horst G; Groot Koerkamp MJ; Tabak HF; Veeneman GH; Van Boom JH
    Nucleic Acids Res; 1983 Dec; 11(24):8595-608. PubMed ID: 6324090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors.
    Zoller MJ; Smith M
    Methods Enzymol; 1983; 100():468-500. PubMed ID: 6225933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.